FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a compound represented in formula (I) or a pharmaceutically acceptable salt thereof, wherein Ra and Rb are each independently either hydrogen or C1-3alkyl; Rc is either hydrogen or C1-3alkyl; and * indicates either R or S configuration. The invention also relates to the intermediates represented in formulas (I-1) and (II-1).
EFFECT: new compounds have been obtained that can be used in medicine as therapeutic agents for the treatment and prevention of pain and diseases associated with pain.
26 cl, 2 dwg, 2 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SUBSTITUTED PYRAZOLE[1,5-a]PYRIMIDINE-7-AMINE DERIVATIVE, COMPOSITION AND PHARMACEUTICAL USE THEREOF | 2022 |
|
RU2824118C1 |
| OXASPIRO DERIVATIVE SUBSTITUTED AT AZABICYCLIC RING, A METHOD OF ITS PRODUCTION AND ITS MEDICAL USE | 2021 |
|
RU2800296C1 |
| HETEROARYL[4,3-c]PYRIMIDINE-5-AMINE DERIVATIVE, ITS PREPARATION METHOD AND ITS MEDICAL APPLICATIONS | 2018 |
|
RU2764655C2 |
| INDAZOLE DERIVATIVE, METHOD FOR PREPARATION AND PHARMACEUTICAL USE THEREOF | 2020 |
|
RU2817737C2 |
| OXASPIRO DERIVATIVE, A METHOD FOR PRODUCTION THEREOF AND USE THEREOF IN MEDICINES | 2016 |
|
RU2733373C2 |
| PHTHALAZINE KETONE DERIVATIVE, METHOD OF OBTAINING THEREOF AND PHARMACEUTICAL APPLICATION | 2011 |
|
RU2564527C2 |
| UREA COMPOUND THAT IS ANTAGONIST OF LPA1 RECEPTOR | 2020 |
|
RU2805922C2 |
| PYRIDAZINE DERIVATIVE INHIBITOR, METHOD OF ITS PREPARATION AND ITS USE | 2020 |
|
RU2807611C2 |
| SUBSTITUTED AMINO SIX-MEMBER SATURATED HETEROALICYCLES AS LONG-ACTING DPP-IV INHIBITORS | 2016 |
|
RU2720488C2 |
| COMPOUNDING, WHICH INHIBITES ACTIVITY OF BTK AND/OR JAK3 KINASES | 2014 |
|
RU2650512C2 |
